Our proprietary Artificial Intelligence platform called bfLEAPTM has been in development for 8 years and has proven to be exceptionally accurate as a prediction tool. In our case study, bfLEAPTM analyzed years of data and hundreds of millions of data points from a major industry and was able to predict outcomes with less than a 0.1% error rate. We are applying the power and robustness of bfLEAPTM to solve clinical trial challenges.

bfLEAPTM is part of Bullfrog AI IP which is a wholly owned subsidiary of Bullfrog AI Holdings.

Home page of this offering   provided by BullFrog AI